Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
32.30
-0.51 (-1.55%)
At close: Dec 5, 2025, 4:00 PM EST
32.94
+0.64 (1.98%)
After-hours: Dec 5, 2025, 6:51 PM EST
Twist Bioscience Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Twist Bioscience stock have an average target of 46.33, with a low estimate of 33 and a high estimate of 62. The average target predicts an increase of 43.44% from the current stock price of 32.30.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Twist Bioscience stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $40 → $37 | Buy | Maintains | $40 → $37 | +14.55% | Nov 17, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $41 | Buy | Initiates | $41 | +26.93% | Nov 4, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $46 → $42 | Buy | Maintains | $46 → $42 | +30.03% | Oct 7, 2025 |
| Barclays | Barclays | Buy Maintains $45 → $40 | Buy | Maintains | $45 → $40 | +23.84% | Oct 2, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $55 → $48 | Strong Buy | Maintains | $55 → $48 | +48.61% | May 6, 2025 |
Financial Forecast
Revenue This Year
443.95M
from 376.57M
Increased by 17.89%
Revenue Next Year
518.57M
from 443.95M
Increased by 16.81%
EPS This Year
-1.55
from -1.30
EPS Next Year
-1.30
from -1.55
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 471.5M | 555.5M | |||
| Avg | 444.0M | 518.6M | |||
| Low | 420.0M | 479.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 25.2% | 25.1% | |||
| Avg | 17.9% | 16.8% | |||
| Low | 11.5% | 7.9% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -1.05 | -0.82 |
| Avg | -1.55 | -1.30 |
| Low | -2.35 | -2.28 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.